Search results
Showing 811 to 825 of 1284 results for social care
research, see the rationale section on coordinating education, health and care (EHC) plan process changes with local services, training...
Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care...
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
Highly specialised technologies evaluation committee members
Biographies for each member of the highly specialised technologies evaluation committee.
This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013
point in the care pathway the views and experiences expressed relate to. As such, it is difficult to fully break down the experience of...
medicines and medicines-related patient safety incidents, compared with usual care or other interventions, in children? Any explanatory...
NICE has developed a medtech innovation briefing (MIB) on RT300 for spinal cord injury rehabilitation .
Selective dorsal rhizotomy for spasticity in cerebral palsy (HTG245)
Evidence-based recommendations on selective dorsal rhizotomy for spasticity in cerebral palsy. This involves cutting nerves in the lower spine that are responsible for muscle rigidity.
View recommendations for HTG245Show all sections
Sections for HTG245
This guideline covers identifying and managing otitis media with effusion (OME), also known as ‘glue ear’, in children younger than 12 years. It aims to improve hearing and quality of life in children with OME.
Evidence-based recommendations on durvalumab (Imfinzi) for locally advanced unresectable non-small-cell lung cancer after platinum-based chemoradiation in adults.
delivered alone or in combination (in conjunction with standard care) compared with standard care alone for young people...
Dupilumab for treating moderate to severe prurigo nodularis (TA955)
Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe prurigo nodularis in adults when systemic treatment is suitable.
Recommendation ID NG181/6 Question Is an integrated care system effective at promoting successful progress for people with complex...
Evidence-based recommendations on quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care.